[1]吴良银a,李文丽b,刘　俊b.基于GEO数据的病毒相关性肝癌潜在生物基因标志物的筛选及生物信息学分析[J].现代检验医学杂志,2021,36(06):106-110.[doi:10.3969/j.issn.1671-7414.2021.06.022]
　WU Liang-yin,LI Wen-li,LIU Jun.Screening and Bioinformatics Analysis of Potential Biomarkers for Virus-associated Hepatocellular Carcinoma Based on GEO Data[J].Journal of Modern Laboratory Medicine,2021,36(06):106-110.[doi:10.3969/j.issn.1671-7414.2021.06.022]
点击复制

基于GEO数据的病毒相关性肝癌潜在生物基因标志物的筛选及生物信息学分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
106-110
栏目:
论　著
出版日期:
2021-12-15

文章信息/Info

Title:
Screening and Bioinformatics Analysis of Potential Biomarkers for Virus-associated Hepatocellular Carcinoma Based on GEO Data
文章编号:
1671-7414（2021）06-106-05
作者:
吴良银a; 李文丽b; 刘　俊b
（粤北人民医院a.检验科；b.生殖医学中心，广东韶关 512025）
Author(s):
WU Liang-yin;  LI Wen-li;  LIU Jun
（a.Department of Clinical Laboratory;b. Reproductive Center,Northern Guangdong People’s Hospital,Guangdong Shaoguan 512025,China）
关键词:
肝细胞癌; 生物信息学; 生物标志物
分类号:
R735.7；R730.43
DOI:
10.3969/j.issn.1671-7414.2021.06.022
文献标志码:
A
摘要:
目的　利用生物信息学分析方法，探索在肝细胞癌预后评估中扮演重要角色的潜在生物标志物。方法　从基因表达综合数据库（gene expression omnibus database，GEO）中收集2019年1月1日～2021年1月1日三个病毒相关性肝细胞癌的转录数据集,共含有52个肝细胞癌肿瘤组织和33个肝细胞癌旁组织（对照组），通过GEO2R进行差异基因的鉴定。利用韦恩图绘制三个数据集的共同差异基因，使用DAVID数据库对共同差异基因进行基因功能富集分析，包括基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析。通过STRING数据库和Cytoscape软件构建蛋白互作网络，根据蛋白之间的连接度，筛选和鉴定出关键基因。基于Kaplan-Meier方法及cBioPortal在线工具，分析关键基因表达与生存预后的相关性。结果　基于三个芯片数据集，共筛选出423个共同差异表达的基因，这些基因主要富集到细胞分裂以及氧化还原等细胞生物学过程；蛋白互作网络共聚焦到20个关键基因，其中BUB1, BUB1B, CDC20, NCAPG, TPX2和UBE2C的表达改变与不良临床结局之间存在显著的相关性。结论　BUB1, BUB1B, CDC20, NCAPG, TPX2和UBE2C在病毒相关性肝细胞癌中异常高表达并且与临床预后相关，可作为病毒相关性肝细胞癌的潜在生物标志物及治疗靶点。
Abstract:
Objective　To explore the potential biomarkers that play an important role in the prognosis of hepatocellular carcinoma (HCC) by bioinformatics analysis. Methods　Three transcriptional data sets of virus associated hepatocellular carcinoma (HCC) from January 1, 2019 to January 1, 2021 were collected from gene expression omnibus database (GEO). There were 52 HCC tumor tissues and 33 paracancerous tissues (control group). The differential genes were identified by GEO2R.The common differential genes of the three datasets were drawn by using Wayne map.The gene function enrichment analysis of the common differential genes was carried out by using DAVID database, including gene ontology (GO) and Kyoto Encyclopedia of genes and genomes (KEGG). The protein interaction network was constructed by using string database and Cytoscape software. The key genes were screened and identified according to the connectivity between proteins. Based on Kaplan-Meier method and cbioportal online tool, the correlation between key gene expression and survival prognosis was analyzed. Results　Based on the three microarray datasets, a total of 423 differentially expressed genes were screened, which were mainly enriched in cell division, redox and other cell biological processes. Protein interaction network focused on 20 key genes, among which the expression changes of BUB1, BUB1B, CDC20, NCAPG, TPX2 and UBE2C were significantly correlated with adverse clinical outcomes. Conclusion　Bub1, BUB1B, CCDC20, NCAPG, TPX2 and UBE2C are highly expressed in viral associated hepatocellular carcinoma and associated with clinical prognosis. They can be used as potential biomarkers and therapeutic targets for viral associated hepatocellular carcinoma.

参考文献/References:

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimatesof incidence and mortality worldwide for 36 cancers in185 countries[J]. CA-A Cancer Journal for Clinicians,2018, 68(6): 394-424.
[2] HIOTIS S P, RAHBARI N N, VILLANUEVA G A，et al. Hepatitis B vs. Hepatitis C infection on viralhepatitis-associated hepatocellular carcinoma[J]. BMCGastroenterology, 2012, 12(1) : 64.
[3] ROXBURGH P, JEFFRY EVANS T R. Systemictherapy of hepatocellular carcinoma: are we makingprogress[J]. Advances in Therapy, 2008, 25(11): 1089-1104.
[4] GUO Xinggang, WANG Zhiheng, ZHANG Jianing,et al. Upregulated KPNA2 promotes hepatocellularcarcinoma progression and indicates prognosticsignificance across human cancer types[J]. ActaBiochimica et Biophysica Sinica, 2019, 51(3) : 285-292.
[5] LI Y B,SUN F N, MA X Y, et al. MiR-888 promotescell migration and invasion of hepatocellular carcinomaby targeting SMAD4[J]. European Review for Medicaland Pharmacological Sciences, 2019, 23(5): 2020-2027.
[6] MA Meilin, XU Haixia, LIU Geng, et al. Metabolisminducedtumor activator 1 (MITA1), an energystress-inducible long noncoding RNA, Promoteshepatocellular carcinoma metastasis[J]. Hepatology(Baltimore, Md.), 2019, 70(1) : 215-230.
[7] ANDREU-PEREZ J，POON C C ，MERRIFIELD RD，et al.Big data for health[J]. IEEE J Biomed HealthInform，2015，19(4):1193-1208.
[8] 沈海涛, 焦荣红, 陆志成, 等. 原发性肝癌患者外周血CD39+,CD73+ 调节性T 细胞和自然杀伤(NK) 细胞的表达及其与肝损伤的相关性[J]. 现代检验医学杂志, 2019, 34(1):10-13.SHEN Haitao, JIAO Ronghong, LU Zhicheng, et al.Correlation between the expression of peripheral bloodCD39+ and CD73+ in regulatory T cells and nature killcell in patients with hepatocellular carcinoma and liverinjury [J]. Journal of Modern Laboratory Medicine,2019, 34(1):10-13.
[9] 张鑫浩, 张涛元, 李俏, 等. 基于GEO 芯片数据的肝癌关键生物标志物的筛选与鉴定及生物信息学分析[J]. 现代检验医学杂志,2020,35(4):26-31.ZHANG Xinhao,ZHANG Taoyuan,LI Qiao,et al.Screening, identification and bioinformatics analysisof key biomarkers for hepatocellular carcinoma basedon GEO chip data [J]. Journal of Modern LaboratoryMedicine,2020,35(4):26-31.
[10] 王蓉, 蔡高涛, 钟小青, 等．血清AFP-L3 和GP-73联合检测对原发性肝癌诊断的Meta 分析[J]. 现代检验医学杂志,2019,34(2):72-75,78.WANG Rong,CAI Gaotao,ZHONG Xiaoqing, etal. Meta analysis of combined detection of serumAFP-L3 and GP-73 in diagnosis of primary livercancer [J]. Journal of Modern Laboratory Medicine,2019,34(2):72-75,78.
[11] CHEN Zide, CHEN Jiehua, HUANG Xuan, et al.Identification of potential key genes for hepatitisB virus-associated hepatocellular carcinoma bybioinformatics analysis[J]. Journal of ComputationalBiology, 2019, 26(5) : 485-494.
[12] QIU Jiannan, ZHANG Shaopeng, WANG Peng, et al.BUB1B promotes hepatocellular carcinoma progressionvia activation of the mTORC1 signaling pathway[J].Cancer Medicine, 2020, 9(21) : 8159-8172.
[13] SONG Yingjian,TAN Juan,GAO Xinhuai, et al.Integrated analysis reveals key genes with prognosticvalue in lung adenocarcinoma[J]. Cancer Managementand Research, 2018, 10: 6097-6108.
[14] ZHANG Qin, HUANG Hai, LIU Ao, et al. Cell divisioncycle 20 (CDC20) drives prostate cancer progressionvia stabilization of β-catenin in cancer stem-likecells[J]. E Bio Medicine, 2019, 42: 397-407.
[15] CHEN Zide, CHEN Jiehua, HUANG Xuan, et al.Identification of potential key genes for hepatitisB virus-associated hepatocellular carcinoma bybioinformatics analysis[J]. Journal of ComputationalBiology, 2019, 26(5): 485-494.
[16] GONG Chengwu, AI Jiyuan, FAN Yun, et al. NCAPGpromotes the proliferation of hepatocellular carcinomathrough PI3K/AKT signaling[J]. Onco Targets andTherapy, 2019, 12: 8537-8552.
[17] HUANG Danhong, JIAN Jie，LI Shuang，et al. TPX2silencing exerts anti-tumor effects on hepatocellularcarcinomaby regulating the PI3K/AKT signalingpathway[J].International Journal of MolecularMedicine, 2019, 44(6): 2113-2122.
[18] CHEN Miaomiao, ZHANG Hongqin, ZHANGGuihong, et al. Targeting TPX2 suppresses proliferationand promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathwayin breast cancer[J]. Biochemical and BiophysicalResearch Communications, 2018, 507(1/4): 74-82.
[19] JIN Dan, GUO Jiwei, WU Yan, et al. UBE2C, directlytargeted by miR-548e-5p, increases the cellular growthand invasive abilities of cancer cells interacting withthe EMT marker protein zinc finger E-box bindinghomeobox 1/2 in NSCLC[J]. Theranostics, 2019, 9(7):2036-2055.
[20] ZHANG Yan, TIAN Suli, LI Xiaodong, et al. UBE2Cpromotes rectal carcinoma via miR-381[J]. CancerBiology & Therapy, 2018, 19(3): 230-238.

相似文献/References:

[1]邓旭,王晓亮.肝细胞癌患者血清趋化因子CXCR12和SA的表达及临床意义[J].现代检验医学杂志,2015,30(06):49.[doi:10.3969/j.issn.1671-7414.2015.06.014]
　DENG Xu,WANG Xiao-liang.Expression and Clinical Significance of Serum CXCR12 and SA in Patients with Hepatocarcinoma[J].Journal of Modern Laboratory Medicine,2015,30(06):49.[doi:10.3969/j.issn.1671-7414.2015.06.014]
[2]毛丽萍,何义民,韩 刚,等.血浆Dickkopf同源物1检测对肝细胞癌的诊断价值[J].现代检验医学杂志,2016,31(05):62.[doi:10.3969/j.issn.1671-7414.2016.05.016]
　MAO Li-ping,HE Yi-min,HAN Gang,et al.Diagnosis Value of Detecting Plasma Dickkopf-1 Patients with Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(06):62.[doi:10.3969/j.issn.1671-7414.2016.05.016]
[3]阮瑞杨,陈修荣,赵世元.抗EZH2自身抗体IgG在肝癌患者血清中的表达及意义[J].现代检验医学杂志,2017,32(02):72.[doi:10.3969/j.issn.1671-7414.2017.02.019]
　RUAN Rui-yang,CHEN Xiu-rong,ZHAO Shi-yuan.Expression and Significance of Anti EZH2 Autoantibodies IgG in Hepatocellular Carcinoma Patient's Serum Samples[J].Journal of Modern Laboratory Medicine,2017,32(06):72.[doi:10.3969/j.issn.1671-7414.2017.02.019]
[4]隆绍平,邓世群,赵世元.PTPN12蛋白表达下调与原发性肝细胞癌患者复发和预后关系研究[J].现代检验医学杂志,2018,33(01):86.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　LONG Shao-ping,DENG Shi-qun,ZHAO Shi-yuan.Association between Downregulation of PTPN12 Protein and Recurrence and Prognosis in Patients with Primary Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(06):86.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[5]毛丽萍,王跃国,王 健,等.CMIA法测定血清DCP与AFP对肝细胞癌的诊断价值[J].现代检验医学杂志,2018,33(06):38.[doi:10.3969/j.issn.1671-7414.2018.06.010]
　MAO Li-ping,WANG Yue-guo,WANG Jian,et al.Diagnostic Value of the Serum DCP and AFP Determined by CMIA in Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(06):38.[doi:10.3969/j.issn.1671-7414.2018.06.010]
[6]吴良银a,李文丽b,刘 俊a.肝细胞癌患者生存预后相关长链非编码RNA(LncRNA)的生物信息学分析[J].现代检验医学杂志,2019,34(04):18.[doi:10.3969/j.issn.1671-7414.2019.04.005]
　WU Liang-yina,LI Wen-lib,LIU Juna.Bioinformatics Analysis of Long-Chain Non-Coding RNA Related to Survival and Prognosis in Patients with Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2019,34(06):18.[doi:10.3969/j.issn.1671-7414.2019.04.005]
[7]陈龙梅,杨振华.基于GEO数据库对类风湿性关节炎相关基因筛选及生物信息学分析[J].现代检验医学杂志,2021,36(02):49.[doi:doi:10.3969/j.issn.1671-7414.2021.02.012]
　CHEN Long-mei,YANG Zhen-hua.Gene Screening and Bioinformatics Analysis of Rheumatoid Arthritis Based on GEO Database[J].Journal of Modern Laboratory Medicine,2021,36(06):49.[doi:doi:10.3969/j.issn.1671-7414.2021.02.012]
[8]陈 偲,李忠辉a,王 颖b.miR-198 通过靶向ZEB2 调控EMT 过程抑制肝癌细胞增殖和迁移的机制研究[J].现代检验医学杂志,2022,37(04):23.[doi:10.3969/j.issn.1671-7414.2022.04.005]
　CHEN Si,LI Zhong-huia,WANG Yingb.Study on the Mechanism of miR-198 Inhibiting the Proliferation and Migration of Hepatoma Cells by Regulating EMT Process by Targeting ZEB2[J].Journal of Modern Laboratory Medicine,2022,37(06):23.[doi:10.3969/j.issn.1671-7414.2022.04.005]
[9]王 路,叶 莎,韩 霞,等.循环外泌体miRNA 检测对肝细胞癌临床诊断效能的Meta 分析[J].现代检验医学杂志,2022,37(04):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
　WANG Lu,YE Sha,HAN Xia,et al.Meta-Analysis of the Diagnostic Value of Circulating Exosomes miRNA Detection for Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2022,37(06):59.[doi:10.3969/j.issn.1671-7414.2021.04.012]
[10]张涛元,丁雪梅,李 俏,等.人非小细胞肺癌组织中转录因子E2F 家族表达与临床病理特征及预后的相关性分析[J].现代检验医学杂志,2022,37(04):87.[doi:10.3969/j.issn.1671-7414.2022.04.017]
　ZHANG Tao-yuan,DING Xue-mei,LI Qiao,et al.Correlation Analysis of Transcription Factor E2F Family Expression with Clinicopathological Features and Prognosis in Human Non-small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2022,37(06):87.[doi:10.3969/j.issn.1671-7414.2022.04.017]
[11]陆 兵,李明虎,文 宁,等.基于TCGA 和HPA 数据库生物学信息分析肝癌组织中YEATS2 表达水平与临床预后及治疗价值[J].现代检验医学杂志,2024,39(03):8.[doi:10.3969/j.issn.1671-7414.2024.03.002]
　LU Bing,LI Minghu,WEN Ning,et al.Analysis of YEATS2 Expression Level in Hepatocellular Carcinoma Tissues with Clinical Prognosis and Therapeutic Value Based on Biological Information from TCGA and HPA Databases[J].Journal of Modern Laboratory Medicine,2024,39(06):8.[doi:10.3969/j.issn.1671-7414.2024.03.002]

更新日期/Last Update: 1900-01-01